临床试验中的自适应设计:系统性审查-第一部分
Mohamed Ben-Eltriki1,2,3, Aisha Rafiq4, Arun Paul4
1Department of Pharmacology and Therapeutics, Max Rady College of Medicine, University of Manitoba, Winnipeg, MB, Canada. mbeneltriki@alumni.ubc.ca.
BMC medical research methodology
|October 4, 2024
概括
适应性设计 (ADs) 提高了临床试验的灵活性和效率. 本综述详细介绍了它们的使用,强调了报告方面的挑战,以及需要更好的指导方针和教育以实现更广泛的采用.
科学领域:
- 临床试验方法论 临床试验方法论
- 生物统计学 生物统计学
- 药物开发 药物开发
背景情况:
- 适应性设计 (ADs) 在临床试验中提供了灵活性,效率和成本节省.
- 研究界对阿尔茨海默病的特征,益处和局限性的广泛理解仍然有限.
- 本系统性审查 (第一部分) 探讨了ADS在已发表的临床试验中的应用.
研究的目的:
- 为适应性临床试验的方法特征提供全面的概述.
- 在适应性试验中确定常见的适应,统计方法和报告实践.
- 为未来的比较和建议奠定基础,特别是对于儿科研究.
主要方法:
- 在MEDLINE,Embase和国际制药摘要 (2010年至2020年4月) 的系统文献搜索.
- 包括临床试验协议,报告和二次分析,使用药物或疫苗的附加剂.
- 提取和总结有关研究特征,调整,统计分析和操作考虑的数据.
主要成果:
- 包括317项适应性试验,主要涉及瘤学 (53%) 和早期发育阶段 (87%).
- 剂量发现设计 (38.2%) 和自适应随机化 (16.7%) 是最常见的;频率主义方法 (64%) 比贝叶斯式 (24%) 更普遍.
- 报道的适应细节不一致,影响了解释和概括性.
结论:
- 适应性临床试验显示出效率的希望,但需要标准化的报告.
- 改善报告准则和教育策略对于有效实施至关重要.
- 应对科学,运营和伦理方面的挑战,将有助于更广泛地采用ADS.
相关概念视频
Clinical Trials
6.6K
Clinical trials are prospective experimental studies conducted on humans to determine the safety and efficacy of treatments, drugs, diet methods, and medical devices. Using statistics in clinical trials enables researchers to derive reasonable and accurate conclusions from the collected data, allowing them to make wise decisions in uncertain situations. In medical research, statistical methods are crucial for preventing errors and bias.
There are four phases in a clinical trial. A phase one...
There are four phases in a clinical trial. A phase one...
6.6K
Study Designs in Epidemiology
188
Epidemiological study designs are fundamental tools for investigating the distribution, determinants, and control of health conditions in populations. They help researchers understand the relationships between exposures and outcomes, and they broadly fall into two categories: "observational" and "experimental" studies.
Observational studies are those where the researcher does not intervene but rather observes natural variations. They include cross-sectional, cohort, and...
Observational studies are those where the researcher does not intervene but rather observes natural variations. They include cross-sectional, cohort, and...
188
Crossover Experiments
2.7K
Crossover experiments, also called the repeated-measurements design, is a study design in which all experimental units are exposed to all treatments in different periods. Crossover experiments are generally used in psychology, the pharmaceutical industry, agriculture, and medicine.
Crossover designs are performed even with smaller sample sizes since the samples can act as their controls. These are better than simple randomized trials since patients are exposed to all the treatments.
Crossover designs are performed even with smaller sample sizes since the samples can act as their controls. These are better than simple randomized trials since patients are exposed to all the treatments.
2.7K
Types of Biopharmaceutical Studies: Controlled and Non-Controlled Approaches
123
Biopharmaceutical studies constitute a vital field aiming to enhance drug delivery methods and refine therapeutic approaches, drawing upon diverse interdisciplinary knowledge. In research methodologies, the choice between controlled and non-controlled studies significantly influences the study's reliability and accuracy.
Non-controlled studies, commonly employed for initial exploration, lack a control group, rendering them susceptible to biases and external influences. In contrast,...
Non-controlled studies, commonly employed for initial exploration, lack a control group, rendering them susceptible to biases and external influences. In contrast,...
123
Experimental Designs
11.1K
An experimental design is a systematic process that allows researchers to evaluate the relationship between dependent and independent variables. There are three widely used types of experimental design - pre-experimental design, true experimental design, and quasi-experimental design. In pre-experimental design, the researcher compares the data before and after some interventions or treatments. The true-experimental design has more than one purposefully created group, a commonly measured...
11.1K
Blinding
2.4K
Blinding is a commonly used method of not telling participants which treatment a subject is receiving. Blinding is a critical part of a randomized control trial or RCT. It reduces the bias that affects the results. In an RCT, blinding is used in the form of a placebo. A placebo effect occurs when untreated subjects falsely believe they have received the treatment and report improved symptoms. A placebo or a dummy treatment is administered to subjects to negate the bias caused by such an effect.
2.4K


